Sujal Shah
Director/Board Member chez OPTHEA LIMITED
Profil
Sujal Shah's current job(s) include being the Chairman at Tvardi Therapeutics, Inc. since 2021 and a Non-Executive Director at Opthea Ltd.
since 2024.
Mr. Shah's former job(s) include being the President, Chief Executive Officer & Director at CymaBay Therapeutics, Inc. from 2017 to 2024, a Director-Health Care Investment Banking at Citigroup, Inc. from 2010 to 2012, and a Vice President-Healthcare Investment Banking Group at Credit Suisse Global Opportunities Advisors LLC from 2004 to 2010.
Mr. Shah's education history includes an undergraduate and graduate degree from Northwestern University and an MBA from the Tepper School of Business.
Postes actifs de Sujal Shah
| Sociétés | Poste | Début |
|---|---|---|
| OPTHEA LIMITED | Director/Board Member | 04/04/2024 |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Chairman | 27/03/2024 |
Anciens postes connus de Sujal Shah
| Sociétés | Poste | Fin |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Chief Executive Officer | 22/03/2024 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/01/2012 |
Credit Suisse Global Opportunities Advisors LLC
 Credit Suisse Global Opportunities Advisors LLC Investment ManagersFinance Part of UBS Group AG, Credit Suisse Global Opportunities Advisors LLC is a private company that provides investment advice. The company is based in New York, NY. | Corporate Officer/Principal | 01/01/2010 |
Formation de Sujal Shah
| Northwestern University | Graduate Degree |
| Tepper School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CITIGROUP INC. | Finance |
| OPTHEA LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Credit Suisse Global Opportunities Advisors LLC
Credit Suisse Global Opportunities Advisors LLC Investment ManagersFinance Part of UBS Group AG, Credit Suisse Global Opportunities Advisors LLC is a private company that provides investment advice. The company is based in New York, NY. | Finance |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Commercial Services |
